Financial Advocates Investment Management Medtronic PLC Transaction History

Financial Advocates Investment Management

$1.78 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$69.43 - $83.43 $269,804 - $324,208	-3,886 Reduced 56.12%	3,039 $250,000
Q3 2023 Oct 27, 2023	BUY	$78.22 - $90.4 $24,952 - $28,837	319 Added 4.83%	6,925 $542,000
Q2 2023 Aug 07, 2023	BUY	$79.47 - $91.38 $13,430 - $15,443	169 Added 2.63%	6,606 $581,000
Q1 2023 May 11, 2023	SELL	$76.72 - $87.58 $1,918 - $2,189	-25 Reduced 0.39%	6,437 $518,000
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $302,129 - $347,976	3,966 Added 158.89%	6,462 $502,000
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $147,934 - $174,607	-1,832 Reduced 42.33%	2,496 $201,000
Q2 2022 Aug 12, 2022	BUY	$87.4 - $113.09 $41,340 - $53,491	473 Added 12.27%	4,328 $389,000
Q1 2022 May 11, 2022	SELL	$100.58 - $112.38 $8.22 Million - $9.19 Million	-81,745 Reduced 95.5%	3,855 $428,000
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $7.94 Million - $10.2 Million	79,807 Added 1377.65%	85,600 $1.93 Million
Q3 2021 Nov 04, 2021	BUY	$122.75 - $135.17 $21,726 - $23,925	177 Added 3.15%	5,793 $726,000
Q2 2021 Aug 03, 2021	SELL	$118.19 - $131.5 $455,267 - $506,538	-3,852 Reduced 40.68%	5,616 $697,000
Q1 2021 May 10, 2021	SELL	$111.18 - $119.74 $280,951 - $302,582	-2,527 Reduced 21.07%	9,468 $1.11 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $239,859 - $279,378	2,385 Added 24.82%	11,995 $1.41 Million
Q3 2020 Nov 04, 2020	BUY	$90.13 - $108.78 $167,551 - $202,222	1,859 Added 23.98%	9,610 $998,000
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $2,775 - $3,409	33 Added 0.43%	7,751 $711,000
Q1 2020 Apr 29, 2020	BUY	$72.92 - $121.3 $20,563 - $34,206	282 Added 3.79%	7,718 $696,000
Q4 2019 Feb 13, 2020	BUY	$104.49 - $114.54 $485,774 - $532,496	4,649 Added 166.81%	7,436 $844,000
Q3 2019 Nov 13, 2019	SELL	$98.02 - $111.18 $4,606 - $5,225	-47 Reduced 1.66%	2,787 $303,000
Q2 2019 Aug 08, 2019	SELL	$84.15 - $99.38 $4,880 - $5,764	-58 Reduced 2.01%	2,834 $276,000
Q1 2019 May 16, 2019	SELL	$82.45 - $93.79 $5,194 - $5,908	-63 Reduced 2.13%	2,892 $263,000
Q4 2018 Feb 14, 2019	SELL	$85.8 - $99.49 $23,080 - $26,762	-269 Reduced 8.34%	2,955 $268,000
Q3 2018 Jul 11, 2019	SELL	$85.91 - $99.17 $1,804 - $2,082	-21 Reduced 0.65%	3,224 $317,000
Q3 2018 Nov 14, 2018	BUY	$85.91 - $99.17 $1,374 - $1,586	16 Added 0.5%	3,245 $0
Q2 2018 Aug 09, 2018	SELL	$77.48 - $87.83 $62,448 - $70,790	-806 Reduced 19.98%	3,229 $278,000
Q1 2018 May 11, 2018	BUY	$76.55 - $87.26 $92,319 - $105,235	1,206 Added 42.63%	4,035 $323,000
Q4 2017 Feb 15, 2018	BUY	$76.93 - $83.5 $217,634 - $236,221	2,829	2,829 $228,000

Others Institutions Holding MDT

# of Institutions

2,285

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

Vanguard Group Inc Valley Forge, PA

123M
Shares

$10.6 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

112M
Shares

$9.65 Billion
0.2% of portfolio
State Street Corp Boston, MA

60.7M
Shares

$5.24 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

32.6M
Shares

$2.81 Billion
0.63% of portfolio
Jpmorgan Chase & CO New York, NY

30M
Shares

$2.59 Billion
0.22% of portfolio

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.

Account